WeVote
Log In

Bill

Bill

HB 2115

Concerning prescription labels for medications used for abortion.

2023-2024 Regular Session Introduced by Mike Chapman and 12 co-sponsors

Washington law requires standardized prescription labels on abortion medications detailing usage, effects, and instructions to enhance patient safety and informed consent.

Effective date 6/6/2024.
0
WeVote Research Nonpartisan
Bill Summary · HB 2115

Legislative bill overview

HB 2115 requires prescription labels on medications used for abortion to display specific information about the medication's purpose, usage instructions, and potential side effects in a standardized format. The bill became law in Washington State on June 6, 2024, following gubernatorial signature in March 2024.

Why is this important

Clear labeling on abortion medications affects patient safety, informed consent, and accessibility to medication abortion services. This is particularly significant as medication abortion (using mifepristone and misoprostol) has become an increasingly common method, and label clarity directly impacts patient understanding of proper use and risk management.

Potential points of contention

  • Reproductive rights perspective: Supporters argue standardized labeling enhances patient safety and autonomy; opponents may view it as unnecessarily burdensome or medicalizing a healthcare decision
  • Federal vs. state authority: The bill operates in a complex legal landscape where FDA labeling requirements exist federally, creating potential overlap or conflict with state-level mandates
  • Implementation details: Disputes may arise over what information is "essential," how detailed labels should be, and whether additional labeling creates barriers to access or merely improves informed consent

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.